Topic: Prostate cancer
Document Owner: Head of Evidence and Quality Hub, National Cancer Control Programme (NCCP)
National Group: National Cancer Control Programme
Effective From: 10 April 2025
Unfortunately, you are using an outdated browser. Please, upgrade your browser to improve your experience with HSE. The list of supported browsers:
The purpose of this National Clinical Guideline is to provide evidence-based recommendations for the use of focal therapy in patients with prostate cancer by integrating the best research evidence with clinical expertise, patient values and experiences.